Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573735
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic DermatitisZhongda HospitalRecruiting
NCT07573735Recruiting
—
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Derm...Zhongda Hospital
NCT07573189
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.University of RedlandsActive Not RecruitingNot Applicable
NCT07573189Active Not Recruiting
Not Applicable
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Mo...University of Redlands
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07573826
Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes in COPD PatientsScholastica Fina Aryu PuspasariNot Yet RecruitingNot Applicable
NCT07573826Not Yet Recruiting
Not Applicable
Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes...Scholastica Fina Aryu Pus...
NCT07572604
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07572604Not Yet Recruiting
Not Applicable
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver Na...
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07574255
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan University HospitalNot Yet Recruiting
NCT07574255Not Yet Recruiting
—
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan Universit...
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07572214
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS Foundation TrustCompleted
NCT07572214Completed
—
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS...
NCT07574424
Normative Values For Physical FitnessRiphah International UniversityEnrolling By Invitation
NCT07574424Enrolling By Invitation
—
Normative Values For Physical FitnessRiphah International Univ...
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573657
Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast CancerBaicheng Central HospitalNot Yet Recruiting
NCT07573657Not Yet Recruiting
—
Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Ax...Baicheng Central Hospital
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572448
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of SafetyUludag UniversityNot Yet Recruiting
NCT07572448Not Yet Recruiting
—
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sens...Uludag University
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07573371
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University HospitalRecruiting
NCT07573371Recruiting
—
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University Hospit...
NCT07573696
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and ChemotherapyWen-zhao ZHONGNot Yet RecruitingPhase 2
NCT07573696Not Yet Recruiting
Phase 2
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib a...Wen-zhao ZHONG
Result Breakdown
Not yet recruiting14 (70%)
Recruiting2 (10%)
Completed2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
Not Specified8 (40%)
not_applicable6 (30%)
Phase 14 (20%)
Phase 41 (5%)
Phase 21 (5%)